[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="USA" width="100%" palette="financial-light"]

Gesundheit

Aktienunternehmen – redaktionelle Illustration
Patentfrieden: GSK und Moderna sichern Impfstoffe
GSK (GSK.L) und Moderna (MRNA.O) haben ihren Patentrechtsstreit ĂĽber COVID-19- und RSV-Impfstoffe auĂźergerichtlich beigelegt, was beiden Unternehmen langwierige Rechtskosten erspart und Planungssicherheit fĂĽr ihre Impfstoffportfolios schafft. FĂĽr Anleger ist die Einigung bedeutsam,...
Prostatakrebsmittel JNJ-6143 – redaktionelle Illustration
JNJ-6143: Wendepunkt in der Prostatakrebsbehandlung
Johnson & Johnson (JNJ) meldete am Samstag, dass sein experimentelles orales Prostatakrebspräparat...
Roche ĂĽbertrifft Erwartungen trotz Markt-HĂĽrden
Der Schweizer Pharmariese Roche (ROG.S) meldete fĂĽr das dritte Quartal 2026 Umsätze, die Analystenerwartungen leicht ĂĽbertrafen – ein Signal,...
Mercks RNAi-Übernahme belebt Börse
AstraZeneca: $1,5 Mrd. KI-Pakt mit Insitro
GSK investiert kräftig in US-Biopharma-Standort
AstraZenecas GroĂźinvestition in Massachusetts
FDA: Tavapadon von AbbVie fĂĽr Parkinson zugelassen
biotech consolidation illustration
Pfizer's $2B Vaccine Standoff Eyes Air-Traffic Fees
Pfizer (PFE) is pressing a roughly $2 billion arbitration claim against Poland and Romania over cancelled Covid-19 vaccine orders, an escalating legal fight that has now swept...
hog margin collapse illustration
Smithfield Faces Pork Segment Loss Amid Margin Collapse
Smithfield Foods (SFD.O) shares fell nearly 2% in extended trading on Tuesday after the pork giant said its fresh pork segment will swing to an adjusted operating loss in Q3, a...
biotech consolidation illustration
Novartis Faces Setbacks in Pipeline Tension
A neuromuscular drug candidate acquired through Novartis’s (NVS) $12 billion Avidity Biosciences deal missed its late-stage primary endpoint, compounding a difficult stretch...
gilead ouro deal illustration
Ionis Secures FDA Nod for First Alexander Therapy
Ionis Pharmaceuticals (IONS.O) secured the first FDA approval for Alexander disease on Thursday, with analysts projecting the injectable therapy could reach $295 million in peak...
Brazil infant formula investment illustration
Nestlé Invests Heavily in Brazil Infant Formula Sector
Nestlé (NESN.S) said Thursday it will commit 2 billion reais ($392.73 million) to its Brazilian nutrition and health division through 2028, anchored by a new infant formula factory...
WEITERE NACHRICHTEN
autoimmune push illustration
Novartis Faces CAR-T Challenges in Autoimmune Trials
JBS beef tariff policy illustration
JBS Billionaire Spurs Shift in U.S. Beef Tariffs
autoimmune push illustration
J&J's Imaavy: A Breakthrough in Rare Blood Disorder
KATEGORIEN